This podium session brings together leading experts to explore how economic evaluation informs vaccine policy, pricing, and access decisions across diverse settings. Presentations will examine methodological advances and real-world applications of cost-effectiveness analysis, budget impact modeling, and value assessment in national immunization programs.
Topics include a comprehensive review of economic evaluations and value considerations shaping ACIP routine vaccine recommendations; empirical evidence on willingness to pay for childhood vaccination in Tanzania, highlighting equity implications; a cost-effectiveness and budget impact analysis of adjuvanted trivalent influenza vaccination for older adults in Argentina; and a scoping review of how indirect effects are incorporated into national vaccine evaluations and recommendations.
Together, these studies illustrate the evolving role of economic evidence in guiding vaccine prioritization, addressing affordability constraints, and integrating equity considerations into decision-making frameworks. Attendees will gain insights into methodological best practices, cross-country perspectives, and policy-relevant findings that can strengthen transparent and equitable immunization strategies.